Filter by: patients
What is Parafon Forte DSC?

Parafon Forte® DSC is a brand name of the drug chlorzoxazone, a skeletal muscle relaxant. It is used for symptomatic treatment of muscle spasm and pain associated with acute musculoskeletal conditions.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Muscle spasms 5 1 Efficacy_slight
Muscle tension 2 1 Efficacy_slight
Osteoarthritis 2 0
Stiffness/Spasticity 1 0
Pain 1 0

See all 7 patients currently taking Parafon Forte DSC

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
0
None
1

Reported Dosages

  3 500mg as needed 3 daily 500 mg daily 2,000 mg daily 2,400 mg daily 4,000 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Parafon Forte DSC (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 1   Did not seem to work: 50%
Side effects too severe 1   Side effects too severe: 50%

See all 2 patients who’ve stopped taking Parafon Forte DSC

Currently Taking Parafon Forte DSC

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Stopped Taking Parafon Forte DSC

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Parafon Forte DSC

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Parafon Forte DSC

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
1 100%

Cost

Paid out of pocket

Cost of Parafon Forte DSC

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.